CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Schrödinger outlines $218M-$228M 2026 ACV outlook with focus on hosted transition and Bunsen early access release

EarningsBunsenPositive
AI Analysis

Summary

Schrödinger provided 2026 annual contract value (ACV) guidance of $218M-$228M, highlighting focus on hosted transition and Bunsen early access release.

Financial Highlights

Guidance

$218M-$228M 2026 ACV outlook

Importance:5/10
Sentiment:
0.50
guidancerevenue_outlookproduct_transitionearly_access
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on May 6, 2026 12:23 AM

Read Original